December 10, 2019 Regulatory Promore Pharma has finalized recruitment of patients in HEAL LL-37 early
November 22, 2019 Regulatory Promore Pharma offentliggör tilläggsprospekt avseende pågående föresträdesemission
November 22, 2019 Regulatory Promore Pharma publishes supplementary prospectus in connection with the ongoing rights issue
October 22, 2019 Regulatory Report from the Extraordinary Shareholders’ Meeting of Promore Pharma AB held on 22 October 2019
October 17, 2019 Non Regulatory Nomination Committee Appointed for the Annual General Meeting 2020 in Promore Pharma
October 4, 2019 Regulatory Promore Pharma genomför en företrädesemission om cirka 75 MSEK, garanterad upp till 80 procent, och tidigarelägger kvartalsrapport
October 4, 2019 Regulatory Promore Pharma Promore Pharma carries out a rights issue of approximately SEK 75 million, underwritten up to 80 percent, and intends to publish its interim report early
August 23, 2019 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för det andra kvartalet 2019
August 23, 2019 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim report for the second quarter 2019
May 21, 2019 Regulatory Report from the Annual General Meeting of Promore Pharma AB held on 21 May 2019
May 15, 2019 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim report for the first quarter 2019
May 15, 2019 Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för det första kvartalet 2019
February 20, 2019 Non Regulatory Invitation to Presentation of Promore Pharma’s Year-end report for 2018
February 20, 2019 Non Regulatory Inbjudan till presentation av Promore Pharmas bokslutskommuniké 2018
February 1, 2019 Regulatory Promore Pharma modifies its Phase III trial of PXL01 and expands the number of clinics in the study
February 1, 2019 Regulatory Promore Pharma modifierar sin fas III-prövning av PXL01 och utökar antalet kliniker i studien